Literature DB >> 12078496

Enzyme-linked immunospot assay for detection of thioredoxin and thioredoxin reductase secretion from cells.

Bita Sahaf1, Anita Söderberg, Christina Ekerfelt, Staffan Paulie, Anders Rosén.   

Abstract

Oxidative stress response was determined in this study by enzyme-linked immunospot (ELISpot) assays for thioredoxin (Trx) and Trx reductase (TrxR). On exposure to oxidative stress, cells can launch a variety of defense mechanisms, including release of antioxidant proteins. The Trx system, consisting of Trx, TrxR, and NADPH, constitutes one of these cellular defense systems for maintenance of a healthy reduction-oxidation (redox) balance. Trx and TrxR are rapidly upregulated and released from monocytes, lymphocytes, and other normal and neoplastic cells on exposure. Secreted Trx and TrxR have proved to be eminent indicators of oxidative stress. Trx is a small, 12-kDa protein released through a leaderless pathway, whereas TrxR, which is a 116-kDa selenoprotein and required for regeneration of Trx, is secreted through the Golgi pathway. In this chapter we present a detailed laboratory bench protocol for enumeration of single cells secreting redox-active Trx and TrxR after oxidative stress exposure. Physiological stimuli (such as interferon gamma, lipopolysaccharide, interleukin 1, and CD23 ligation; and phorbol 12-myristate 13-acetate and ionophore) as well as UV light and hydrogen peroxide were used to generate oxidative stress, and some are presented in detail. The protocol includes a description of cell isolation, preparation, handling, and development of ELISpot plates, troubleshooting notes, presentation of results, statistical evaluation, and comments on alternative sources of materials and manufacturer Web addresses. We concluded that the ELISpot assay is a useful method for detection of single cells secreting the redox-active proteins Trx and TrxR after oxidative stress exposure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12078496     DOI: 10.1016/s0076-6879(02)53033-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  2 in total

1.  Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.

Authors:  Sally Arai; Bita Sahaf; Balasubramanian Narasimhan; George L Chen; Carol D Jones; Robert Lowsky; Judith A Shizuru; Laura J Johnston; Ginna G Laport; Wen-Kai Weng; Jonathan E Benjamin; Joanna Schaenman; Janice Brown; Jessica Ramirez; James L Zehnder; Robert S Negrin; David B Miklos
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113

2.  Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study.

Authors:  Suofu Ye; Xiaofeng Chen; Yi Yao; Yueqin Li; Ruoxuan Sun; Huihui Zeng; Yongqian Shu; Hanwei Yin
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.